Active ingredient in Ozempic, Wegovy shows early promise for treating alcohol use disorder among those with obesity: Study The active ingredient found in popular weight-loss drugs used by millions of people may also help reduce alcohol use in those with obesity, a new study finds
Ahern T, Tobin AM, Corrigan M, et al
Semaglutide is well-known for causing nausea, bloating, and changes in bowel habits, especially during the first few months of treatment
Effective for long-term obesity management in patients with a BMI over 25 kg/m, leading to an average weight loss of 4.45 kg (9.8 lbs) in 12 months
International Journal of Molecular Sciences , 25(5), 2952
You can even take a synbiotic formula (which includes both prebiotics and probiotics) to save on time and effort and nourish your gut the right way